참고문헌
- Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006;17:2034-2047. https://doi.org/10.1681/ASN.2005101085
- Mazzuchi N, Carbonell E, Fernqndez-Cean J. ESRD patients without co-morbid risk factors at the start of haemodialysis are ideal as survival comparison population. Nephrol Dial Transplant 1999;14:1091-1096. https://doi.org/10.1093/ndt/14.5.1091
- Kim JK, Kim SG, Kim HJ, Song YR. Cardiac risk assessment by gated single-photon emission computed tomography in asymptomatic end-stage renal disease patients at the start of dialysis. J Nucl Cardiol 2012;19:438-47. https://doi.org/10.1007/s12350-011-9497-2
- Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-543. https://doi.org/10.1161/01.CIR.97.6.535
- Rabbat CG, Treleaven DJ, Russell JD, Ludwin D, Cook DJ. Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis. J Am Soc Nephrol 2003;14:431-439. https://doi.org/10.1097/01.ASN.0000047560.51444.3A
- Brown KA, Altland E, Rowen M. Prognostic value of normal technetium-99m-sestamibi cardiac imaging. J Nucl Med 1994;35:554-557.
- Hachamovitch R, Hayes S, Friedman JD, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol 2003;41:1329-1340. https://doi.org/10.1016/S0735-1097(03)00125-6
- Elhendy A, Schinkel A, Bax JJ, van Domburg RT, Poldermans D. Long-term prognosis after a normal exercise stress Tc-99m sestamibi SPECT study. J Nucl Cardiol 2003;10:261-266. https://doi.org/10.1016/S1071-3581(02)43219-9
- Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995;26:639-647. https://doi.org/10.1016/0735-1097(95)00218-S
- Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996;93:905-14. https://doi.org/10.1161/01.CIR.93.5.905
- Hatta T, Nishimura S, Nishimura T. Prognostic risk stratification of myocardial ischaemia evaluated by gated myocardial perfusion SPECT in patients with chronic kidney disease. Eur J Nucl Med Mol Imaging 2009;36:1835-1841. https://doi.org/10.1007/s00259-009-1165-2
- Kato M, Matsumoto N, Nakano Y, et al. Combined assessment of myocardial perfusion and function by ECG-gated myocardial perfusion single-photon emission computed tomography for the prediction of future cardiac events in patients with type 2 diabetes mellitus. Circ J 2011;75:376-382. https://doi.org/10.1253/circj.CJ-10-0794
- Matsuo S, Nakajima K, Horie M, Nakae I, Nishimura T; J-ACCESS Investigators. Prognostic value of normal stress myocardial perfusion imaging in Japanese population. Circ J 2008;72:611-617.
- Weiner DE, Tighiouart H, Elsayed EF, et al. Inflammation and cardiovascular events in individuals with and without chronic kidney disease. Kidney Int 2008;73:1406-1412. https://doi.org/10.1038/ki.2008.75
- Menon V, Greene T, Wang X, et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int 2005;68:766-772. https://doi.org/10.1111/j.1523-1755.2005.00455.x
- Wanner C, Zimmermann J, Schwedler S, Metzger T. Inflammation and cardiovascular risk in dialysis patients. Kidney Int Suppl 2002;61(Suppl 80):S99-S102.
- Glassock RJ, Pecoits-Filho R, Barberato SH. Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol 2009;4 Suppl 1:S79-S91. https://doi.org/10.2215/CJN.04860709
- Zoccali C, Benedetto FA, Mallamaci F, et al. Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int 2004;65:1492-1498. https://doi.org/10.1111/j.1523-1755.2004.00530.x
- Zoccali C, Benedetto FA, Mallamaci F, et al. Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients. J Am Soc Nephrol 2004;15:1029-1037. https://doi.org/10.1097/01.ASN.0000117977.14912.91
- Cerasola G, Nardi E, Palermo A, Mule G, Cottone S. Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review. J Nephrol 2011;24:1-10.
- De Vriese AS, Vandecasteele SJ, Van den Bergh B, De Geeter FW. Should we screen for coronary artery disease in asymptomatic chronic dialysis patients? Kidney Int 2012;81:143-151. https://doi.org/10.1038/ki.2011.340
피인용 문헌
- Association between gut dysbiosis and chronic kidney disease: a narrative review of the literature vol.49, pp.10, 2018, https://doi.org/10.1177/03000605211053276